Therapeutic and Diagnostic Value of Caspase-12 and Study of Growth Differentiation Factor-15 in Patients with Acute Myocardial Infarction
Abstract
Background: To investigate the therapeutic and diagnostic value of caspase-12 and study of growth differentiation factor-15 (GDF-15) in patients with acute myocardial infarction (AMI).
Methods: Overall 78 patients with AMI admitted to Weifang People's Hospital Brain Hospital, Weifang, China from Apr 2016 to Apr 2019 were enrolled as AMI group. Seventy five non-AMI people undergoing physical examination during the same period were enrolled as non-AMI group. The expression levels of caspase-12 and GDF-15 were detected and compared. The correlation between the expressions of GDF-15, caspase-12 and clinical characteristics and efficacy was detected. Single and combined detection of GDF-15 and caspase-12 were performed analyze their role in the early diagnosis, the prediction of efficacy, and the guidance of clinical therapy.
Results: After treatment, the levels of GDF-15 and caspase-12 in AMI group were significantly lower than those before treatment (P<0.001). The expression levels of GDF-15 and caspase-12 were significantly correlated with blood pressure (P<0.05). The expression levels of GDF-15 and caspase-12 were significantly negatively correlated with clinical efficacy in AMI group. The diagnostic value of combined detection of GDF-15 and caspase-12 was higher than that of single diagnosis. The levels of serum caspase-12 and GDF-15 proteins were significantly up-regulated in AMI patients. With the better therapeutic effect, the levels of serum caspase-12 and GDF-15 proteins decreased significantly.
Conclusion: The levels of serum caspase-12 and GDF-15 proteins may be a key indicator in the clinical diagnosis of acute myocardial infarction and may also be used to guide the treatment of AMI patients and predict the therapeutic efficacy.
2. Yang AY, Bai YN, Xie ZD (2017). The trend of coronary heart disease mortality and disease bur-den in Jinchang cohort from 2001 to 2013. Chin I Dis Control Prev, 21: 261-264, 269.
3. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, et al (1999). Contribution of trends in survival and coronary-event rates to changes in cronary heart disease mortality: 10-year results from 37 Who MONICA Project populations. Lancet, 353(9164): 1547-1557.
4. Dégano IR, Salomaa V, Veronesi G, et al (2015). Twenty-five-year trens in myocardial infarction at-tack and mortality rates, and case-fatality, in six Eu-ropean populations. Heart, 101(17): 1413-1421.
5. Peeters A, Nusselder WJ, Stevenson C, et al (2011). Age pecific trends in cardiovascular mortality rates in the Netherlands between 1980 and 2009. Eur J Epidemiol, 26(5): 369-373.
6. Ago T, Sadoshima J (2006). GDF15, a cardioprotec-tive TGF-beta superfamily protein. Circ Res, 98(3): 294-297.
7. Brown DA, Breit SN, Buring J, et al (2002). Concen-tration in plasma of macrophage inhibitory cyto-kine-1 and risk of cardiovascular events in wom-en: a nested case-control study. Lancet, 359(9324): 2159-2163.
8. Ramu A, Banerjee SK (2015). GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective. J Diabetes Res, 2015: 490842.
9. Cotter G, Voors AA, Prescott MF, et al (2015). Growth differentiation factor 15 (GDF-15) in pa-tients admitted for acute heart failure: results from the RELAX-AHF study. Eur J Heart Fail, 17(11): 1133-1143.
10. Lambert JR, Whitson RJ, Iczkowski KA, et al (2015). Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the pros-tate. Prostate, 75(3): 255-265.
11. Ünal B, Alan S, Başsorgun Cİ, et al (2015). The diver-gent roles of growth differentiation factor-15 (GDF-15) in benign and malignant skin patholo-gies. Arch Dermatol Res, 307(7): 551-557.
12. Afrin R, Arumugam S, Soetikno V, et al (2015). Cur-cumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic re-ticulum stress-mediated apoptosis in diabetic rats. Free Radic Res, 49(3): 279-289.
13. Huerauf DJ, Marcinko M, Gude N, et al (2006). Acti-vation of the unfolded protein response in in-farcted mouse heart and hypoxic cultured cardiac myocytes. Circ Res, 99(3): 275-282.
14. Boya P, Cohen I, Zamzami N, et al (2002). Endo-plasmic reticulum stress induced cell death requires mitochondrial membrahe permeabilization. Cell Death Differ, 9(4): 465-467.
15. Breckenridge DG, Germain M, Mathai JP, et al (2003). Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene, 22(53): 8608-8618.
16. Cai W, Chen WL, Fu HL (2017). Effect of Muxiang Shunqi Pill on Digestive Disorders of Prephase Uremia Patients and Its Mechanism. Zhongguo Zhong Xi Yi Jie He Za Zhi, 37(1): 34-38.
17. Xue W, Zhao Y, Yuan M, et al (2019). Chinese herb-al bath therapy for the treatment of uremic pruri-tus: meta-analysis of randomized controlled trials. BMC Complement Altern Med, 19(1): 103.
18. Jing R, Liu Q, Xie Q, et al (2015). Correlation between GDF 15 gene polymorphism and the collateral circulation in acute non-ST segment elevated my-ocardial infarction. Int J Clin Exp Med, 8(8): 14383-14387.
19. Sayed AS, Xia K, Yang TL, et al (2013). Circulating microRNAs: a potential role in diabnosis and probnosis of acute myocardial infarction. Dis Markers, 35(5): 561-566.
20. Allan JJ, Feld RD, Russell AA, et al (1997). Cardiac troponin levels are normal or minimally elevated after transthoracic cardioversion. J Am Coll Cardiol, 30(4): 1052-1056.
21. Lauer B, Niederau C, Kühl U, et al (1997). Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol, 30(5): 1354-1359.
22. Maiscl A (2007). Biomarkcrs in heart failure. Does prognostic utility to clinical futility? J Am Coll Cardiol, 50(11): 1061-1063.
23. Wollert KC (2007). Growth-differentiation factor-15 in cardiovascular disease:from bench to bedside, and back. Basic Res Cardiol, 102(5): 412-415.
24. Eggers KM, Kempf T, Lind L, et al (2012). Relations of growth differentiation factor-15 to biomarkers rellecting vascular pathologies in a population-based sample of elderly subjects. Scand J Clin Lab Invest, 72(1): 45-51.
25. Nakagawa T, Yuan J (2000). Cross-talk between two cysteine protease families Activation of aspase-12 by calpain in apoptosis. J Cell Biol, 150(4): 887-894.
26. Schernthaner C, Lichtenauer M, Wernly B, et al (2017). Multi-Biomarker Analysis in Patients with Acute Myocardial Infarction. Eur J Clin Invest, 47(9): 638-648.
27. Khan SQ, Ng K, Dhillon O, et al (2009). Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J, 30(9): 1057-1065.
28. Zeng JY, Du JJ, Pan Y, et al (2016). Calcium-Sensing Receptor in Human Peripheral Blood T Lym-phocytes Is Involved in the AMI Onset and Pro-gression through the NF-κB Signaling Pathway. Int J Mol Sci, 17(9): 1397.
29. Hanatani S, Izumiya Y, Takashio S, et al (2014). Urowth diffcrentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hy-pertensivc hearts. Heart Vessels, 29(2): 231-237.
30. Xu XY, Nie Y, Wang FF, et al (2014). Growth differ-entiation factor (GDF)-15 blocks norepinephrine induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation. J Bio Chem, 289(14): 10084-10094.
31. Sun Y, Zhang T, Li L, et al (2015). Induction of Apoptosis by Hypertension via Endoplasmic Re-ticulum Stress. Kidney Blood Press Res, 40(1): 41-51.
| Files | ||
| Issue | Vol 49 No 12 (2020) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijph.v49i12.4817 | |
| Keywords | ||
| Acute myocardial infarction (AMI) Therapeutic value Diagnostic value | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
